October 20, 2021 — Day by day, the prospects for treating obesity are getting better. Late on Monday, detailed results from the longest study yet of tirzepatide came out in Lancet. This was a study using this new drug in people with type 2 diabetes, but the average BMI of these patients was 33. None of them had a […]
October 11, 2021 — As rationalizations go, imagining huge health benefits from eating more plant-based diets is not terrible. Trisha Pasricha writes in the Washington Post that pneumonia, diverticulitis, diabetes, and cancers are linked to regularly eating meat. She even points to a study of COVID and plant-based diets to illustrate how beneficial such diets might be: “In a […]
September 27, 2021 — It was an exciting possibility. At ObesityWeek 2019, Novartis scientist Laura Coleman presented fascinating results for an experimental drug, bimagumide, in obesity. In a phase 2 study, it yielded impressive improvements in body composition for people with obesity. It wasn’t just making people lose body fat. It helped them also gain muscle mass. Then, it […]
September 9, 2021 — Healthy, green – plant-based – alternatives to food products from animals are generating quite a buzz right now. Restaurants are riding a wave of interest in this concept. With the planet burning and flooding everywhere we turn, wouldn’t it be nice if dining at HipCityVeg could help turn things around? New Forms of Food Multiplying […]
August 9, 2021 — Could it be that innovation and competition for better obesity care will overtake the health problem of obesity? We see several signs pointing to this. A decade ago, it was tough to get FDA to take obesity innovation seriously. So big pharma research was running from the challenge. Sanofi had invested heavily in developing rimonabant […]
July 8, 2021 — This is seriously messed up. Let’s consider the case of two innovative new drugs and how health insurance will cover them. Each of them treats a chronic disease that can devastate a person’s health and quality of life. But these are different diseases and very different drugs. One offers a breakthrough in effectiveness. In fact, […]
July 6, 2021 — Cambridge Professor Sadaf Farooqi calls it a tour de force of genetics. Researchers from Regeneron and nine international research centers sequenced genetic exomes in 645,626 persons. With this painstaking research, they’ve found genetic sequences that protect some people from obesity. These sequences hard wire a person for leanness. In a world that prizes a lean […]
June 30, 2021 — “After 24 hours, the participants indicated that they occasionally felt embarrassed, self-conscious, and that life, in general, was less satisfying.” Nonetheless, researchers from the University of Otago in New Zealand think they have an “attractive alternative” for weight loss. It’s a dental device with magnets. It attaches to a person’s teeth to prevent them from […]
June 8, 2021 — The mantra for the Wegovy brand of semaglutide just approved by FDA for obesity is clear enough – game changer. Great. Obesity is not a game, but health plans treat it like a 19th century game of hot potato: “Jack’s alive, and likely to live If he dies in your hand, you’ve a forfeit to […]
June 5, 2021 — Experts labeled it as a gamechanger months ago. So it is certainly good news to see semaglutide approved by FDA, now with a brand name, Wegovy. With good reason, people see this new drug as something that can bring radical progress to treating obesity. On average, it’s more effective than other drugs for obesity. Compared […]
